Overview

Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients

Status:
NOT_YET_RECRUITING

Trial end date:
2028-01-28

Target enrollment:

Participant gender:

Summary

This study is a prospective, multicenter, parallel-controlled clinical trial designed to evaluate the therapeutic efficacy of Huaier Granules for proteinuria occurring in lung cancer patients undergoing treatment with either Bevacizumab or Anlotinib.

Phase:

PHASE4

Details

Lead Sponsor:

Fudan University

Treatments:

anlotinib
Bevacizumab